- Home
- WLII vs LFMD Comparison
WLII vs LFMD Comparison
Compare WLII & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WLII | LFMD |
|---|---|---|
| Founded | 2025 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 218.1M |
| IPO Year | 2026 | 2012 |
Fundamental Metrics
Financial Performance| Metric | WLII | LFMD |
|---|---|---|
| Price | $10.18 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 75.0K | ★ 652.2K |
| Earning Date | N/A | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | N/A | $18.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $10.16 | $2.06 |
| 52 Week High | $10.29 | $5.96 |
Technical Indicators
Market Signals| Indicator | WLII | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 38.80 |
| Support Level | N/A | N/A |
| Resistance Level | $10.29 | $3.46 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 12.50 | 47.65 |
Price Performance
Historical ComparisonAbout WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares
Willow Lane Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.